From: High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination
Risk factor
OR
95% CI
Glycopeptide prescription
6.9
3.1–15.4
West-Europe
2.2
1.04–4.6
5 th minute Apgar score <8
1.8
1.1–3.0
GA <32weeks
1.7
1.02–2.8
North-Europe
0.6
0.3–0.99